News

New Partners in Frankfurt

We are pleased to have won two new partners in the provision of the OkuStim therapy for you: the Augenzentrum Frankfurt and Teichmann Ohren- und Augenwelt.

Short waiting times for appointments, good transport connections and international expertise are now available close to you.

Read more

Imminent blindness comparable to state of emergency

A recent social court ruling paves the way for the retroactive reimbursement of OkuStim therapy for retinitis pigmentosa (RP). A patient had filed a lawsuit because her health insurance company had refused to cover the costs, as there was no threat of blindness and the therapeutic benefit of TES had not yet been evaluated by the Federal Joint Committee (G-BA).

Read more

Electrical Stimulation as Therapy Option for RP

The amendment of the ophthalmological guideline for hereditary retinal, choroidal and visual pathway diseases now also refers to electrical stimulation as a therapy option for retinitis pigmentosa (RP). This gives ophthalmologists a concrete option for the symptomatic treatment of RP.

Read more

Retina UK Konferenz 2021

Retina UK's professional and annual conferences will be held online in April. Registration is now open.
We will be presenting OkuStim Therapy as part of the "Update from Industry" session in the Annual Conference programme on 17 April.
OkuStim therapy has been available in the UK since December 2020.

Read more

RP, a rare disease

Most of the more than 6,000 different rare diseases are of genetic origin. Retinitis Pigmentosa (RP) is one of them.
There are therapies for only about 3% of rare diseases - OkuStim therapy for RP is one of them. It can preserve vision.

Read more

New Competence Centre London

OkuStim therapy is now available for you in the UK.

Please follow the link for contact details.

Read more